Ochre Bio
$39.6Mtotal raised · 2 rounds on record
$30Mlatest round · Venture round · Oct 2022 · 4 yr ago
6backers · Expa, Y Combinator
A-ratedvisa sponsor licence, United Kingdom
Overview
Ochre Bio is a London biotechnology company founded in 2019 that develops RNA medicines for chronic liver disease. It tests candidates on donated human livers kept alive on perfusion machines rather than relying only on animal models. The company partners with pharmaceutical firms on liver-targeted therapeutic programmes.
Funding and backers
Total raised
$39.6M
2 rounds on record
Latest round
$30M
Venture round · Oct 2022 · 4 yr ago
Backers
6
Expa, Y Combinator
The money's age
Long since its last round
48 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 13, 2024
Partnership Irish-founded Ochre Bio teams up with GSK to tackle liver disease · Silicon Republic
May 16, 2023
Board appointment Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors · Nasdaq
Oct 15, 2022
Raised a round Venture round $30M · Chemical & Engineering News
May 11, 2022
Launched Ochre Bio Launches 'Liver ICU' in the United States to Evaluate Effects of RNA Therapies on Human Liver Performance · businesswire.com
Jun 16, 2021
Raised a round Seed $9.6M · led by Khosla Ventures · businesswire
Jan 2020
Went through Y Combinator
Nov 4, 2019
Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2022 | $30M | — | Chemical & Engineering News |
| Seed | Jun 2021 | $9.6M | Khosla Ventures lead | businesswire |
Registers and programsofficial lists and records that name the company
| Legal entity | OCHRE BIO LTD | Companies House |
| Registered | 4 Nov 2019 |
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Science HepaRegeniX aims at curing liver diseases by reversing the disease path through liver regeneration.
Innovative therapeutics that target serious viral and liver diseases Assembly Bio is applying our passion, scientific ingenuity and deep…
Early detection of cancer, liver disease and over 500 other diseases. Receive a personal health action plan with full body MRI and blood…
Delivering genetic medicines that transcend liver-based limitations, liberating patients from disease.
Relation Therapeutics is a London biotechnology company founded in 2019 that applies graph machine learning to disease biology. Its…
We're using AI to transform donated human organs & tissues into high-fidelity biological data, shared insight, and faster decisions.
Visa sponsorship
A-rated
Sponsor licence
Skilled Worker
Visa route
0
Open roles in United Kingdom
In the register as Ochre Bio, Oxford
Alert me
UK Home Office · checked Nov 5, 2026 · Visa details by country
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
NorrskenVia a fund
Backed VCVia a fund
Hoxton VenturesVia a fund
ExpaVia a fund
Entrepreneur FirstVia a fund
530 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Meet the man trying to eradicate the need for liver transplants
The post Meet the man trying to eradicate the need for liver transplants appeared first on Ochre Bio.
Read more
Report
Why the liver is the body's most misunderstood organ
The post Why the liver is the body's most misunderstood organ appeared first on Ochre Bio.
Read more
Report
How old is YOUR liver? Take our 6-step test to find out if you're at risk of fibrosis and cirrhosis… and the easy lifestyle tweaks to de-age the organ FAST
The post How old is YOUR liver? Take our 6-step test to find out if you're at risk of fibrosis and cirrhosis… and the easy lifestyle tweaks to de-age the organ FAST appeared first on Ochre Bio.
Read more
Report
All the economic wins Keir Starmer wants to bag in China
The post All the economic wins Keir Starmer wants to bag in China appeared first on Ochre Bio.
Read more
Report
Ochre Bio and GSK complete early research into human liver
The post Ochre Bio and GSK complete early research into human liver appeared first on Ochre Bio.
Read more
Report
Ochre Bio Completes Human Liver Functional Genomics and Single-cell Datasets in Partnership with GSK
OXFORD, England, Nov. 18, 2025 /PRNewswire/ - Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, today announced the successful completion of the research phase of its collaboration with GSK, delivering two comprehen
Read more
Report
OCHRE BIO COMPLETES HUMAN LIVER FUNCTIONAL GENOMICS AND SINGLE-CELL DATASETS IN PARTNERSHIP WITH GSK
Read more
Report
Derisking clinical trials requires a 'human first' approach
The post Derisking clinical trials requires a 'human first' approach appeared first on Ochre Bio.
Read more
Report
Can the UK reclaim its status as a life sciences leader?
The post Can the UK reclaim its status as a life sciences leader? appeared first on Ochre Bio.
Read more
Report
This company aims to end the need for liver transplants - as thousands die every year on the waitlist
The post This company aims to end the need for liver transplants - as thousands die every year on the waitlist appeared first on Ochre Bio.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ